CD19-CAR T-cell therapy resets the EBV+ autoreactive B cell repertoire in autoimmune disease
Ya'el Courtney, Mahesh Pandit, Laura S van Dam…·William H Robinson
This study shows CD19-CAR T-cell therapy depletes EBV+ autoreactive B cells and resets their repertoire, leading to sustained remission, while rituximab does not.